Copyright Licensing Agency releases new Pharmaceutical Collaboration Licence


Companies holding an existing Pharmaceutical Licence from the Copyright Licensing Agency (“CLA“) have been given the opportunity to upgrade to a new Trial Pharmaceutical Collaboration Licence (“TPCL“), at no extra cost.  The TPCL will enable licensed companies to legally share copies of material from CLA covered publications with similarly licensed organisations on projects or products where they are working collaboratively. 

The TPCL is designed to offer existing licence holders extended permissions to enjoy the benefits of sharing in an industry which relies heavily on collaboration between companies in the development of new products.  

The TPCL has be introduced on a trial basis and feedback will be requested from licensees later this year for any suggested improvements. 

Further information on the TPCL and how to apply can be found on the CLA website.  The CLA has also published FAQs which can be found here.


DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© DLA Piper | Attorney Advertising

Written by:


DLA Piper on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.